Candida Auris News and Research

RSS

The rise of Candida auris: Understanding its origin and persistence

In a recent study published in the PLOS Pathogens journal, researchers from the University of Texas Health Science Center at San Antonio in the United States (US) explored the existing perspectives on the origination, resistance, and transmission of Candida auris, a human fungal pathogen.

28 Mar 2023

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

A recent study reported growing cases of Candida auris in North Italy.

27 Mar 2023

Possible pathways of C. auris emergence and the hypothetical role of interspecies transmission

Researchers summarized the current understanding of the emergence and ecologic niches of Candida auris.

27 Mar 2023

Candida auris escapes innate immunity through metabolic reprogramming

A team of scientists from Australia and Israel demonstrates that Candida auris, a fungus associated with life-threatening and drug-resistant infections, escapes the host's innate immune response by destroying macrophages through metabolic reprogramming. The fungus is also capable of escaping antimicrobial inflammatory response.

23 Mar 2023

Antifungal tolerance in Candida auris contributes to treatment failure

A recent study published in the journal Biomedicines aimed to determine the antifungal tolerance of Candida auris (C. auris) to all three classes of antifungal drugs commonly used to treat invasive candidiasis.

23 Mar 2023

High-resolution mass spectrometric rapid identification of Candida auris

A recent study published in the Journal of Fungi used a novel OrbitrapTM high-resolution mass spectrometric technology coupled with liquid chromatography to identify geographically different clades of Candida auris (C. auris) isolates. This proof-of-concept methodology could accurately detect C. auris in the microbiology laboratory.

23 Mar 2023

Candida auris infection without epidemiologic links to a prior outbreak

The Centers for Disease Control and Prevention (CDC) has classified Candida auris (C. auris) as an urgent public threat due to its role in elevating mortality, its ability to persist in hospital environments, and the high possibility of developing pan-drug resistance.

23 Mar 2023

Researchers receive $3 million-plus NIH grant to develop treatment for drug-resistant fungus

With a new $3 million-plus grant from the National Institutes of Health (NIH), Case Western Reserve University researchers are examining the next level of treatment for Candida auris (C.auris), a multidrug-resistant yeast that causes serious infection and, in some cases, death.

30 Nov 2022

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Researchers evaluated the trends in Candida auris infections among European Union/European Economic Area (EU/EUA) nations between 2020 and 2021.

21 Nov 2022

Enormous rise in Acinetobacter bloodstream infection cases in initial two years of COVID-19

In a new study, researchers investigated Acinetobacter species bloodstream infection (BSI) case counts from a subset of laboratory data continuously reported during the initial two years of SARS-CoV-2 infections, i.e., from 2020 to 2021.

21 Nov 2022

An unprecedented list of health-threatening fungi released by the WHO

The WHO fungal priority pathogens list ranks pathogens that pose a serious risk of morbidity and mortality in humans.

27 Oct 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

Covid sewage surveillance labs join the hunt for monkeypox

The same wastewater surveillance techniques that have emerged as a critical tool in early detection of covid-19 outbreaks are being adapted for use in monitoring the startling spread of monkeypox across the San Francisco Bay Area and some other U.S. communities.

9 Aug 2022

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on antimicrobial resistance.

18 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Drug-resistant, pathogenic yeasts found on surfaces of apples and other fruits

When they're prepared for transport, apples and other fruits are often treated with a fungicide to prevent spoilage and extend shelf life.

31 Mar 2022

Antimicrobial resistance in COVID-19

Researchers discuss the impact of this extensive use of antibiotics on the rise of antimicrobial resistance.

16 Mar 2022

CDC to invest $2.1 billion to improve safety and quality of healthcare in the U.S.

Today, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control activities across the U.S. public health and healthcare sectors.

18 Sep 2021

The newest disease detection tool for covid and beyond: Poop

Since reopening campus at the University of California-San Diego last summer, university officials have relied on the tried-and-true public health strategies of testing and contact tracing. But they have also added a new tool to their arsenal: excrement.

16 Aug 2021

Researchers develop smart wound dressings with built-in healing sensors

Researchers have developed smart wound dressings with built-in nanosensors that glow to alert patients when a wound is not healing properly.

28 Jun 2021

Candida Auris News and Research

The rise of Candida auris: Understanding its origin and persistence

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

Possible pathways of C. auris emergence and the hypothetical role of interspecies transmission

Candida auris escapes innate immunity through metabolic reprogramming

Antifungal tolerance in Candida auris contributes to treatment failure

High-resolution mass spectrometric rapid identification of Candida auris

Candida auris infection without epidemiologic links to a prior outbreak

Researchers receive $3 million-plus NIH grant to develop treatment for drug-resistant fungus

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Enormous rise in Acinetobacter bloodstream infection cases in initial two years of COVID-19

An unprecedented list of health-threatening fungi released by the WHO

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Covid sewage surveillance labs join the hunt for monkeypox

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Drug-resistant, pathogenic yeasts found on surfaces of apples and other fruits

Antimicrobial resistance in COVID-19

CDC to invest $2.1 billion to improve safety and quality of healthcare in the U.S.

The newest disease detection tool for covid and beyond: Poop

Researchers develop smart wound dressings with built-in healing sensors

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News